We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.225 | 5.81% | 4.10 | 4.05 | 4.15 | 4.275 | 3.825 | 3.88 | 29,115,559 | 16:25:52 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -4.32 | 21.05M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/7/2024 22:10 | This will go in the rabbit at 3.5p tomorrow and come out at 1.45p | the white rabbit | |
25/7/2024 22:04 | This could go in administration when they run out of money, it's a scam. | genghis_khan_ | |
25/7/2024 19:51 | 22 Posts about the company mentioning my poster name today. You would think they would have better things to do. And remember not once have I told people to buy, but because I like the shares, they see it as some sort of threat, bless. IMO | hazl | |
25/7/2024 18:37 | Beeksy After your imaginary shower/bath , could you stop asking others for links and do your own research Your pal ZICO | z1co | |
25/7/2024 18:12 | Or the buying could start | petersmith6 | |
25/7/2024 18:01 | Z1CO16 Jul '24 - 22:07 - 947 of 1048 0 3 1 The last delay by NICE was announced by the company at 9.28am yet a lot already knew over night and started selling at the open. Same could happen again | genghis_khan_ | |
25/7/2024 17:50 | You are too kind. It's great just using the filter button and makes it much easier to read. | daddy warbucks | |
25/7/2024 17:44 | If NICE were not going to approve CYP2C19 then why would they say quote: "NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance." That is the HUGE POSITIVE clue that they will APPROVE. | z1co | |
25/7/2024 17:37 | Another cracking post from our host , NICE | z1co | |
25/7/2024 17:36 | LOLOL You're just a clown. Are you keeping your imaginary short until Wednesday ,, hahahahaha You should have shorted CLCO from 2p instead of going LONG and you would have made £100,000 , instead you've LOST over £100,000. That's how clever you are hahahahahahahah | z1co | |
25/7/2024 17:36 | see you tomorrow 08.00 while you're in the bath re-read the header and your 25 plus posts from today and come back better. ............ update ... only one permanent ban so far and just a couple of short term ones .. | brownstone22 | |
25/7/2024 17:32 | If NICE were not going to approve CYP2C19 then why would they say quote: "NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance." That is the HUGE POSITIVE clue that they will APPROVE. | z1co | |
25/7/2024 17:31 | More for these two clowns On the basis of what NICE has said APPROVAL IS A CERTAINTY: In addition to being dominant in cost effectiveness models, NICE recommends the Genedrive® as the point-of-care platform of choice for CYP2C19 genotyping strategies in the NHS. The decision was based on several differentiating features of the Genedrive® technology; 1) its greater coverage of genetic variants compared to the other point-of-care system assessed, permitting increased equitable access to healthcare across ethnic populations 2) no requirement for cold-chain storage logistics 3) its ability to integrate with patient electronic healthcare systems. The UK's National Institute for Health and Care Excellence ("NICE") has recommended in draft guidance, that the Genedrive® CYP2C19-ID test should be used as the point-of-care test of choice in the NHS before clopidogrel administration in the management of IS and TIA patient Resolution has now concluded, so we plan to publish as soon as we can. NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance. | z1co | |
25/7/2024 17:23 | So, you made it up then.Righty. | premium beeks | |
25/7/2024 17:21 | If NICE were not going to approve CYP2C19 then why would they say quote: "NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance." That is the HUGE POSITIVE clue that they will APPROVE. If traders like Beeksy are too THICK to understand then it will their failure | z1co |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions